HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund

Active

Assistance listing
93.461
Agency
Grant awards
Not on record

Program facts

Also known as
HRSA COVID-19 Claims Reimbursement for the Uninsured Program (UIP) and the COVID-19 Coverage Assistance Fund (CAF)
Treasury account
  • 75-0140-0-1-550
More information

Program details come from SAM.gov Assistance Listings. Updated .

About this program

The Health Resources and Services Administration (HRSA) operated the COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund (CFDA 93.461) to reimburse eligible health care providers for testing, treatment, and vaccine administration for uninsured individuals; however, HRSA is no longer accepting claims as of the Fiscal Responsibility Act of 2023, and no additional claim payments will be made under either program.

The Uninsured Program reimbursed providers generally at Medicare rates for COVID-19 testing, treatment, and vaccine administration for uninsured patients. The Coverage Assistance Fund reimbursed providers at the national Medicare rate for vaccine administration and for patient charges related to COVID-19 vaccination, including copayments, deductibles, and coinsurance for vaccine administration. Both programs have concluded their claims-acceptance phase, though reporting and auditing requirements continue under the terms and conditions established for each program.

Eligibility for reimbursement varied by program and provider type. Recipients subject to the program's requirements fall under 45 CFR part 75 Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Non-federal entities expending $750 thousand or more in federal awards during a fiscal year are subject to single or program-specific audit; those expending less are exempt from federal audit requirements but must maintain records available for review by federal agencies and the Government Accountability Office.

This program is not currently accepting new claims or applications. Organizations should verify compliance with ongoing reporting and auditing obligations if they received reimbursement under either program during its active phase. Additional guidance and terms and conditions are available at https://www.hrsa.gov/CovidUninsuredClaim and https://www.hrsa.gov/covid19-coverage-assistance.

Objective and description

Objective

The COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for the Uninsured Program - also known as the Uninsured Program - provides claims reimbursement to eligible health care provi

Description

The HRSA COVID-19 Uninsured Program provides claims reimbursement to eligible health care providers, generally at Medicare rates, for testing, treatment, and vaccine administration for uninsured individuals for COVID-19. The CAF provides claims reimbursement to eligible health care providers reimbursed at the national Medicare rate for vaccine administration, and for patient charges related to COVID-19 vaccination, including co-payments for vaccine administration, deductibles for vaccine administration, and co-insurance.

Eligibility

Applicant eligibility

Eligibility varies. With the passage of the Fiscal Responsibility Act of 2023 and related rescission of program funds, no additional claims payments will be made under the Uninsured Program or Coverage Assistance Fund. Per the Terms and Conditions of each Program, all reporting and auditing requirements will continue without disruption.

Credentials and documentation

Documentation varies. For additional information, please see www.hrsa.gov/provider-relief/about/covid-uninsured-claim and www.hrsa.gov/provider-relief/about/covid-19-coverage-assistance. In 2022, the HRSA COVID-19 Uninsured Program and the COVID-19 Coverage Assistance Fund (CAF) stopped accepting claims due to a lack of sufficient funds. With the passage of the Fiscal Responsibility Act of 2023 and related rescission of program funds, no additional claims will be made under the Uninsured Program (UIP) or Coverage Assistance Fund (CAF). Please see the discontinuation of the UIP program at https://www.hrsa.gov/provider-relief/about/covid-19-coverage-assistance

Uses of assistance

Prior to discontinuation of payments, this funding was for claims reimbursements for COVID-19 testing, treatment, and vaccine administration.

Length and time phasing of assistance

See Terms and Conditions at www.hrsa.gov/provider-relief/compliance/terms-conditions.

How to apply

Application procedure

Sections of 45 CFR part 75, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, apply to this program - refer to compliance requirements below for additional details.

Award procedure

HRSA is no longer accepting claims for reimbursement.

Deadlines

HRSA is no longer accepting claims.

Quick answers

What is Assistance Listing 93.461?

Assistance Listing 93.461 is HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund, a federal grant program run by Health Resources and Services Administration (Department of Health and Human Services).

What is the CFDA number for HRSA COVID-19 Claims Reimbursement for the Uninsured Program and the COVID-19 Coverage Assistance Fund?

Its CFDA number is 93.461: Assistance Listing numbers were called CFDA numbers before 2018.

On GovTribe

See this program's full record

  • Every grant award and opportunity under it
  • Funding by recipient, agency and assistance type
  • Alerts for new opportunities
  • Ask GovTribe AI about this program